OFATUMUMAB vs OLAPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OFATUMUMAB vs OLAPARIB: Safety Overview
| Metric | OFATUMUMAB | OLAPARIB |
|---|---|---|
| Total FAERS Reports | 29,913 | 18,274 |
| Deaths Reported | 695 | 5,496 |
| Death Rate | 2.3% | 30.1% |
| Hospitalizations | 3,616 | 3,471 |
| Average Patient Age | 47.5 yrs | 62.3 yrs |
| % Female Patients | 74.9% | 79.9% |
| FDA Approval Date | N/A | Aug 17, 2017 |
| Manufacturer | Novartis Pharmaceuticals Corporation | AstraZeneca Pharmaceuticals LP |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Discontinued |